A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog

A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JCONREL.2012.03.016
P698PubMed publication ID22709414

P50authorMalou Henriksen-LaceyQ37840518
Dennis ChristensenQ37840535
Jan Pravsgaard ChristensenQ43182017
Peter AndersenQ54029065
Thomas LindenstrømQ56884096
Claire-Anne SiegristQ64006386
Yvonne PerrieQ91734501
Else Marie AggerQ111279894
Karen Smith KorsholmQ117250581
Arun T. KamathQ117250583
Paul-Henri LambertQ117250585
P2093author name stringAnne-Francoise Rochat
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectimmunologic adjuvantQ967453
P304page(s)468-476
P577publication date2012-06-01
P1433published inJournal of Controlled ReleaseQ6295046
P1476titleA cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog
P478volume160

Reverse relations

cites work (P2860)
Q38098855A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant
Q91440678A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice
Q40805619A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice
Q37332628Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators
Q41678461Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani
Q95482822Cell recruitment and antigen trafficking in afferent lymph after injection of antigen and poly(I:C) containing liposomes, in aqueous or oil-based formulations
Q48695533Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
Q36500269Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
Q59798720Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization
Q35593603Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants
Q36154772Harnessing nanoparticles for immune modulation
Q54211947Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).
Q61803783Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
Q26765446Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
Q38068245Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Q34418761Liposomes as vaccine delivery systems: a review of the recent advances
Q54690087Manufacturing Methods for Liposome Adjuvants.
Q42724009Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland
Q36909492Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates
Q42235032Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms
Q52655234Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.
Q35664854Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?
Q37834166Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses.
Q89783316Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral Disease
Q45831503Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants
Q49829267The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
Q39190589The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs

Search more.